High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions

  1. Maurino, J.
  2. Sotoca, J.
  3. Sempere, Á.P.
  4. Brieva, L.
  5. López de Silanes, C.
  6. Caminero, A.B.
  7. Terzaghi, M.
  8. Gracia-Gil, J.
  9. Saposnik, G.
Zeitschrift:
Patient

ISSN: 1178-1661 1178-1653

Datum der Publikation: 2021

Ausgabe: 14

Nummer: 2

Seiten: 241-248

Art: Artikel

DOI: 10.1007/S40271-020-00454-3 GOOGLE SCHOLAR